Thiopurines: Recent Topics and Their Role in the Treatment of Inflammatory Bowel Diseases

被引:21
|
作者
Tominaga, Keiichi [1 ]
Sugaya, Takeshi [1 ]
Tanaka, Takanao [1 ]
Kanazawa, Mimari [1 ]
Iijima, Makoto [1 ]
Irisawa, Atsushi [1 ]
机构
[1] Dokkyo Med Univ, Dept Gastroenterol, Mibu, Tochigi, Japan
关键词
inflammatory bowel disease; ulcerative colitis; crohn' s disease; thiopurine; pharmacological action; biological agents; INDUCED EARLY LEUKOPENIA; EVIDENCE-BASED CONSENSUS; LOW-DOSE AZATHIOPRINE; CROHNS-DISEASE; LONG-TERM; S-METHYLTRANSFERASE; ULCERATIVE-COLITIS; NUDT15; POLYMORPHISMS; CLINICAL-PRACTICE; JAPANESE PATIENTS;
D O I
10.3389/fphar.2020.582291
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Ulcerative colitis (UC) and Crohn's disease (CD) are chronic inflammatory bowel diseases (IBD) of unknown etiology, characterized by repeated relapse and remission. The efficacy of thiopurine in IBD was first reported in the late 1960s. Thiopurines are used to alleviate the symptoms of IBD, especially UC. These drugs have a steroid-sparing potential and are widely used for the purpose of maintaining long-term remission in steroid-dependent cases. Therefore, thiopurines tend to be used long-term, but adverse events that accompany long-term use, such as lymphoproliferative disorders, must be monitored with care. In contrast, thiopurine plays a critical role in controlling the immunogenicity of biologics. Furthermore, although thiopurine is an old drug, new findings, including the prediction of serious adverse events such as severe alopecia and acute advanced leukopenia, by nudix hydrolase 15 gene polymorphism analysis, as well as the possibility of appropriate drug monitoring by detailed analysis of 6-thioguanine nucleotides have been clarified. However, the consequences of thiopurine withdrawal have not been determined and further studies, including randomized controlled trials, are necessary to answer the clinical question regarding the scenarios in which thiopurine withdrawal is possible.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Thiopurines in inflammatory bowel disease revisited
    Baer, Florian
    Sina, Christian
    Fellermann, Klaus
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (11) : 1699 - 1706
  • [22] Recent Advances in Nanoparticle-Mediated Treatment of Inflammatory Bowel Diseases
    Nedelcu, Andreea
    Mosteanu, Ofelia
    Pop, Teodora
    Mocan, Teodora
    Mocan, Lucian
    APPLIED SCIENCES-BASEL, 2021, 11 (01): : 1 - 18
  • [23] Pharmacogenetics of Thiopurines in Inflammatory Bowel Disease
    Derijks, L. J. J.
    Wong, D. R.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (02) : 145 - 154
  • [24] Use of thiopurines in inflammatory bowel disease
    Pascal Frei
    Luc Biedermann
    Ole Haagen Nielsen
    Gerhard Rogler
    World Journal of Gastroenterology, 2013, (07) : 1040 - 1048
  • [25] Role of the gut microbiome in the pathogenesis and treatment of inflammatory bowel diseases
    Kempski, Jan
    Huber, Samuel
    INNERE MEDIZIN, 2022, 63 (10): : 1022 - 1027
  • [26] Evolving role of diet in the pathogenesis and treatment of inflammatory bowel diseases
    Levine, Arie
    Boneh, Rotem Sigall
    Wine, Eytan
    GUT, 2018, 67 (09) : 1726 - +
  • [27] The Role of Gut Microbiome in the Pathogenesis and the Treatment of Inflammatory Bowel Diseases
    Vidal-Gallardo, Andrea
    Benitez, Juan E. Mendez
    Rios, Leticia Flores
    Meza, Luis F. Ochoa
    Perez, Rodrigo A. Mata
    Romero, Edgar Martinez
    Beltran, Andres M. Vargas
    Hernandez, Jose L. Beltran
    Banegas, Douglas
    Perez, Brenda
    Ramirez, Marily Martinez
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (02)
  • [28] The role of the intestinal microbiota in the pathogenesis and treatment of inflammatory bowel diseases
    Miyoshi, Jun
    Qiao, Yuqi
    Chang, Eugene B.
    SEMINARS IN COLON AND RECTAL SURGERY, 2018, 29 (01) : 21 - 27
  • [29] Thiopurines in inflammatory bowel disease revisited
    Florian Br
    Christian Sina
    Klaus Fellermann
    World Journal of Gastroenterology, 2013, (11) : 1699 - 1706
  • [30] RISKS OF CANCERS IN THIOPURINES USERS WITH INFLAMMATORY BOWEL DISEASES AS COMPARED TO NON-INFLAMMATORY BOWEL DISEASES PATIENTS: A TERRITORY-WIDE STUDY
    Zheng, Kelvin Yu Chen
    Guo, Chuan-Guo
    Wong, Irene O. L.
    Chen, Lijia
    Leung, Wai Keung
    GASTROENTEROLOGY, 2019, 156 (06) : S630 - S630